Calibo, Nicky J.

HRN: 21-77-10  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/04/2022
CEFUROXIME 750MG (VIAL)
08/04/2022
08/11/2022
IV
750mg
Q8
T/C Acute Appendicitis
Waiting Final Action 
08/04/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/04/2022
08/11/2022
IV
500mg
Q8
T/C Acute Appendicitis
Waiting Final Action 
12/18/2022
CEFUROXIME 500MG (TAB)
12/18/2022
12/25/2022
ORAL
500mg/tab
BID
Increased WBC; UTI
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: